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Edited by Lukas HuberAbstract Integrins are type I heterodimeric (a/b) cell adhesion
molecules. They trigger cell-signaling by recruiting cytosolic
molecules to their cytoplasmic tails. Integrin a cytoplasmic tail
contributes towards integrin function speciﬁcity, an important
feature of integrins having diﬀerent a subunits but sharing the
same b subunit. Herein, we show that the src family kinase
Hck co-capped selectively with leukocyte integrin aMb2 but not
aLb2 or aXb2. This was disrupted when the aM cytoplasmic tail
was substituted with that of aL or aX. Co-capping was recovered
by aL or aX cytoplasmic tail truncation or forced separation of
the a and b cytoplasmic tails via salt-bridge disruption.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Integrins mediate many biological processes [1]. Although
they lack intrinsic enzymatic activities, integrins transduce
intracellular signal events by recruiting signaling proteins to
their cytoplasmic tails [2]. In some integrins, several a subunits
can pair with a common b subunit as exempliﬁed in the leuko-
cyte b2 integrins (aLb2 CD11aCD18; aMb2 CD11bCD18; aXb2
CD11cCD18; aDb2 CD11dCD18). Respiratory burst and
apoptosis of neutrophils are eﬀected diﬀerently by antibody
cross-linking of diﬀerent b2 integrins [3,4]. Furthermore,
aLb2 and aMb2 showed dissimilar activation kinetics on che-
mokine stimulated monocytes [5]. Therefore, we hypothesized
that the a cytoplasmic tail regulates the interaction between b2
cytoplasmic tail and cytosolic protein(s).
Herein, we studied the co-localization of aMb2 with Hck
(haematopoietic cell kinase) [6]. Integrin aMb2 (also known as
CR3 or Mac-1) mediates type II phagocytosis of iC3b-opso-
nized particles by neutrophils and macrophages [7,8]. Hck, a
member of the src family kinases (SFKs), is expressed in mye-
loid cells and was shown to translocate towards phagosome
containing serum-opsonized zymosan (OZ) in neutrophils
[9,10]. Hck was reported to co-localize with aMb2 around phag-
osome in aMb2 transfectants [11]. We adopted a similar ap-
proach using aMb2 transfectants to examine the eﬀect of aMb2
tail modiﬁcations on Hck recruitment. We report: (i) the abro-
gation of aMb2 and Hck co-cap when the aM tail was substi-
tuted with that of aL or aX; (ii) its restoration when this aL or*Corresponding author. Fax: +65 6 7913856.
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salt-bridge between the a and b2 tails; (iii) the identiﬁcation of a
region within b2 tail that is required for aMb2 and Hck co-cap-
ping. Together, these data suggest a primary role of the integrin
a tail in regulating b2 tail interaction with cytosolic factors.2. Materials and methods
2.1. Reagents, antibodies, and cells
All general reagents were purchased from Sigma, St. Louis, MO.
These monoclonal antibodies (mAbs) were gifts from diﬀerent sources:
MHM24 (aLb2-speciﬁc) [12] was from Prof. A.J. McMichael (John
Radcliﬀe Hospital, Oxford, UK); LPM19c (aMb2-speciﬁc) [13] and
KB43 (aXb2-speciﬁc) [14] were from Dr. K. Pulford (LRF Diagnostic
Unit, Oxford, UK). The b2-speciﬁc mAb KIM202 and b2-speciﬁc acti-
vating mAb KIM185 [15] was a gift from Dr. M. Robinson (CellTech,
Slough, UK). The mAb IB4 (b2 integrin heterodimer-speciﬁc) [16]
hybridoma was purchased from ATCC, Manassas, VA. These cell lines
were purchased from ATCC: human monocytic THP-1; human T lym-
phoblastic MOLT-4; and Chinese hamster ovary epithelial CHO-K1.
2.2. Expression plasmids
The aM and b2 pcDNA3.0 mammalian expression constructs were
described previously [17]. The numbering of the aL, aM, aX, and b2
amino acids is based on that of Barclay et al. [18]. p59 Hck cDNA
was generated by RT-PCR. Total mRNA was isolated from THP-1
cells using a mRNA extraction kit (Roche Diagnostics GmbH, Ger-
many) followed by RT and PCR with appropriate primers using a
RT-PCR kit (Qiagen, Valencia, CA). RT-PCR product was cloned
into shuttle vector pXJ40-HA [19,20] generating Hck-HA-pXJ40.
Hck cDNA was ampliﬁed by PCR using this template and relevant pri-
mer pair for subsequent cloning into pcDNA3.0 (Invitrogen, Carlsbad,
CA). The reverse primer was designed to remove the stop codon from
Hck cDNA and to incorporate six His residues at its C-terminus. The
ﬁnal expression construct Hck-6-His pcDNA3.0 was used in the trans-
fection of CHO-K1 cells. The His-tag facilitates detection of Hck in
transfectants. A similar strategy was employed for the generation of
Lck-6-His pcDNA3.0 except that the Lck and CD4 cDNAs were gen-
erated by RT-PCR of total mRNA from MOLT-4 cells. The aML and
aMX tail chimeras were generated by restriction digest substitution of
aM tail in aM pcDNA3 with the aL or aX full-length tail using the
restriction sites SspBI and XbaI. The aMLP1110*, aMX N1133*,
b2M740*, b2S734*, b2N727*, and b2K702* variants were generated by
introducing a stop codon immediately after the amino acid indicated
using relevant primer pairs and the Quikchange site-directed muta-
genesis kit (Stratagene, La Jolla, CA). b2D709R was constructed sim-
ilarly except that a primer pair encoding the substitution of Asp709 to
Arg was used. All constructs generated were veriﬁed by sequencing
(Research Biolabs, Singapore).
2.3. Cell culture and transfection
THP-1 and MOLT-4 cells were maintained in RPMI 1640. CHO-K1
cells were maintained in Ham’s F12K. The culture media were supple-
mented with 10% (v/v) heat-inactivated foetal bovine serum (HI-FBS),
100 IU/mL penicillin, and 100 lg/mL streptomycin. All culture media,blished by Elsevier B.V. All rights reserved.
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Transfection of CHO-K1 with expression plasmids was performed
using Lipofectamine2000 (Invitrogen).
2.4. Flow cytometry and cell adhesion assay
Samples for ﬂow cytometry analyses were prepared as described pre-
viously [17]. Samples were analyzed on a FACS Calibur (Becton Dick-
inson Biosciences, Mountain View, CA) using the CellQuest software.
Cell adhesion assay was performed as described except that iC3b was
coated in wells of Polysorp microtiter plate (Nunc, Roskilde, Den-
mark) [17]. iC3b was prepared according to previous report [21]. In
standard adhesion assay, iC3b (7.5 lg/mL) was used for coating of
wells. In titration adhesion assays, diﬀerent concentrations of iC3b
(0.3, 0.8, 2.5, and 7.5 lg/mL) were used. KIM185 and aMb2 func-
tion-blocking LPM19c were used at 10 lg/mL in the adhesion assays.
Fluorescence signal, which corresponds to the number of cells adhering
to iC3b-coated well, was measured on a FL600 ﬂuorescence plate read-
er (Bio-Tek Instruments, Winooski, VT).
2.5. Phagocytosis
Zymosans (Sigma) were labeled with rhodamine red-X succinim-
idyl ester (Molecular Probes, Eugene, OR) according to manufac-
turer’s instructions. Labeled zymosans were incubated in Hanks’Fig. 1. Hck co-capped with aMb2. (A) FACS analyses of THP-1 cells witho
(anti-aMb2), and KB43 (anti-aXb2) (shaded histograms) or an irrelevant mAb
in PMA-treated THP-1 cells. (C) Hck but not Lck co-capped with mAb LPM
CD4. (D) Co-capping of Hck with aMb2 in CHO-K1 transfectants. aMb2 was
speciﬁc activating mAb KIM185, or b2-speciﬁc mAb KIM202 that is non-fu
10 lm.balanced salt solution (HBSS) containing 1 mM CaCl2, 0.5 mM
MgCl2, and 10% (v/v) normal human serum for 30 min at 37 C to
promote opsonization. Opsonized zymosans (OZ) were washed in
HBSS. Aggregates were dispersed by brief sonication. CHO-K1
transfectants cultured in chambered slides (Nunc) were serum-starved
for 30 min and OZ added at a ratio of 5:1 (OZ:cell) in culture med-
ium without HI-FBS under culture conditions for 3 h to allow phago-
cytosis of OZ.2.6. Immunoﬂuorescence and confocal microscopy
Suspension THP-1 cells were treated with 10 ng/mL phorbol 12-
myristate, 13-acetate (PMA) (Sigma) in chambered slides (Nunc)
under culture conditions for 24 h before analyses. Treated cells were
highly adherent and showed comparable expression level of aLb2,
aMb2, and aXb2. Co-capping analyses of PMA-treated THP-1 cells
were performed by treating cells with 10 lg/mL of mAb MHM24
(anti-aLb2), LPM19c (anti-aMb2), or KB43 (anti-aXb2) together with
FITC-conjugated sheep anti-mouse IgG antibody (1:300 dilution)
(Sigma) in PBS for 30 min at 37 C to allow cross-linking of the inte-
grins. Thereafter, cells were ﬁxed in 3.7% (w/v) paraformaldehyde in
PBS for 10 min at 4 C. Cells were permeabilized with 0.2% (v/v) Tri-
ton X-100 in modiﬁed cytoskeleton stabilization (CSK) buﬀer
(100 mM NaCl, 300 mM sucrose, 3 mM MgCl2, 1 mM EGTA,ut or with PMA-treatment using mAbs MHM24 (anti-aLb2), LPM19c
(open histogram). (B) Hck co-capped with aMb2 but not aLb2 or aXb2
19c-cross-linked aMb2 in CHO-K1 transfectants. Lck co-capped with
cross-linked with function-blocking heterodimer-speciﬁc mAb IB4, b2-
nction-blocking nor activating. Representative images are shown. Bar:
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incubated with rabbit anti-Hck antibody (1:50 dilution) (Santa Cruz
Biotechnology Inc., Santa Cruz, CA) followed by TRITC-conjugated
swine anti-rabbit antibody (1:100 dilution) (Dako Cytomation, Den-
mark).
For co-capping analyses in CHO-K1 transfectants demonstrating
Hck but not Lck association with aMb2, the primary mAbs LPM19c
(anti-aMb2) (10 lg/mL) and SK3 (anti-CD4) (1:50 dilution) (Becton
Dickinson) were used. The detection of transfected Hck or Lck in per-
meabilized CHO-K1 cells was performed using the rabbit anti-His tag
antibody (1:50 dilution) (Santa Cruz) followed by TRITC-conjugated
swine anti-rabbit antibody (Dako). For detecting co-localization of
Hck with diﬀerent aMb2 mutants having deletions in the b2 cytoplasmic
tail, similar procedures were used. For the study demonstrating consti-
tutive association of Hck with aMb2, 10 lg/mL of mAbs IB4, KIM185,
or KIM202 was used.Fig. 2. Integrin cytoplasmic tail variants. (A) The aL, aM, aX, and b2 ectod
boxes. The Arg and Asp residues of a and b tails, respectively, involved in sal
GFFKR motif is underlined. (B) The aML or aMX variants are illustrated
aMLP1110* and aMXN1133* contain deletions of the a cytoplasmic tails. (C)
shown. The other b2 tail variants are illustrated.Detection of transfected Hck around rhodamine red-labeled OZ-
containing phagosome in CHO-K1 cells bearing aMb2 or its variants
was achieved using rabbit anti-His tag antibody followed by FITC-
conjugated goat anti-rabbit antibody (1:100 dilution) (Sigma).
All prepared samples were mounted in mounting medium (Dako)
and analyzed on a Zeiss LSM 510 confocal laser scanning microscope
(Carl Zeiss, Germany) equipped with a 63· objective. Images were pro-
cessed using software LSM 510, version 3.2.3. Results
3.1. Hck co-capped with aMb2 but not aLb2 or aXb2
We examined Hck co-capping with the b2 integrins in human
monocytic THP-1 cells. In our hands, suspension THP-1 cellsomains and transmembrane regions are represented by diﬀerent ﬁlled
t-bridge formation are marked (*). The conserved membrane proximal
by a black box followed by the aL or aX tail sequence, respectively.
The b2D709R variant with Asp709 substituted with Arg (black box) is
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aMb2 (Fig. 1A). THP-1 cells display macrophage-like diﬀeren-
tiation in response to phorbol esters treatment [22]. Therefore,
THP-1 cells were treated with PMA to promote their diﬀeren-
tiation into macrophage-like cells that were highly adherent
and showed comparable expressions of the b2 integrins. Spe-
ciﬁc b2 integrins on PMA-treated THP-1 cells were cross-
linked with relevant mAbs together with FITC-conjugated
secondary antibody. Confocal microscopy revealed propensity
and signiﬁcant co-capping of Hck with aMb2 but not with aLb2
and aXb2 (Fig. 1B). To verify Hck and aMb2 co-capping spec-
iﬁcity, CHO-K1 transfectants expressing aMb2 and Hck or an-
other SFK Lck, which is not known to interact with aMb2,Fig. 3. Eﬀect of a tail on aMb2 and Hck co-localization. (A) FACS analysis o
heterodimer-speciﬁc mAb IB4 (shaded histogram) and irrelevant mAb (open
KIM185 further augmented the binding. Adhesion was speciﬁc because it wa
(C) Hck clustering (white arrow) around phagosome was prominent in aMb2 b
clustering around phagocytosed-OZ by counting an entire ﬁeld. aMb2 va
aMLP1110*b2, and aMXN1133*b2 transfectants phagocytosed OZ with concomwere examined. Importantly, Hck but not Lck co-capped with
cross-linked aMb2 (Fig. 1C). However, Lck co-capped eﬃ-
ciently with its known interactor CD4 [23]. Because the
aMb2-speciﬁc function-blocking mAb LPM19c was used in
the cross-linking of aMb2, we extended the analyses using the
heterodimer-speciﬁc function-blocking mAb IB4 [16], the b2-
speciﬁc activating mAb KIM185 [15], and the b2-speciﬁc
mAb KIM202 that is not known to activate or abrogate
aMb2 function (unpublished data) (Fig. 1D). In all cases,
Hck co-capping with aMb2 was detected. It is therefore appar-
ent that the association of Hck with aMb2 is constitutive. Of
note, the SFK c-Src is shown to bind to platelet integrin aIIbb3
constitutively [24].f aMb2, aMLb2, and aMXb2 expression on CHO-K1 transfectants using
histogram). (B) Adhesion of transfectants to iC3b. b2-activating mAb
s abrogated in the presence of aMb2 function-blocking mAb LPM19c.
ut not in aMLb2 or aMXb2 transfectants. (D) % Transfectants with Hck
lue taken as 100%. (E) aMb2D709R, aMLb2D709R, aMXb2D709R,
itant clustering of Hck. Representative images are shown. Bar: 10 lm.
R.-H. Tang et al. / FEBS Letters 580 (2006) 4435–4442 44393.2. Substitution of aM tail with aL or aX tail abrogated Hck
recruitment to aMb2-mediated phagosome
The length and composition of the aL, aM, and aX tails diﬀer
(Fig. 2A). To test whether these variations could account forFig. 4. Expression and ligand-binding proﬁles of aMb2 variants. (A) FA
heterodimer-speciﬁc mAb IB4 (open histogram) and irrelevant mAb (shaded
coated with diﬀerent concentrations (0.3, 0.8, 2.5, and 7.5 lg/mL) of iC3b in t
was speciﬁc in all cases because binding of transfectants to the wells coate
abrogated in the presence of aMb2 function-blocking mAb LPM19c.Hck and aMb2 co-capping speciﬁcity, we generated tail variants
of aM. The aM tail (Lys
1114-Gln1137) was replaced with aL
(Lys1087-Asp1145) or aX (Lys
1110-Lys1144) tail to generate aML
and aMX variants, respectively (Fig. 2B). CHO-K1 transfectantsCS analyses of CHO-K1 transfected with aMb2 or variants using
histogram). (B) CHO-K1 transfectants were allowed to adhere wells
he presence or absence of b2-activating mAb KIM185. Binding to iC3b
d with the highest concentration of iC3b (7.5 lg/mL) was eﬀectively
Fig. 5. Deﬁning the region in integrin b2 tail that is required for Hck
recruitment. Hck co-capped eﬃciently with aMb2, aMb2M740*,
aMb2S734* but not with aMb2N727* and aMb2K702* in CHO-K1
transfectants. Representative images are shown. Bar: 10 lm.
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aMb2 as determined by FACS (Fig. 3A). The binding properties
of these variants to aMb2 ligand iC3b, a serum complement
opsonin, were also comparable to aMb2 transfectants
(Fig. 3B). Further, aMb2, aMLb2 and aMXb2 transfectants
phagocytosed OZ (unpublished observation). Hck accumula-
tion around OZ-containing phagosomes were reported in
aMb2 CHO-K1 transfectants [11]. To extend our study in the
context of a biological process, co-localization of Hck with
aMLb2 and aMXb2 during phagocytosis was examined. CHO-
K1 transfected with Hck and aMb2, aMLb2, or aMXb2 were al-
lowed to phagocytose rhodamine red-labeled OZ followed by
immunoﬂuorescence staining of Hck and confocal microscopy
analyses (Fig. 3C and D). Prominent Hck accumulation at the
periphery of the phagocytosed-OZ was detected in aMb2 trans-
fectants but poorly in aMLb2 or aMXb2 transfectants.
3.3. Tail truncation or salt-bridge disruption restored aMLb2 or
aMXb2 recruitment of Hck
Nuclear magnetic resonance studies reveal hydrophobic and
electrostatic contacts between integrin aIIb and b3 tails [25,26].
The proximity of aL and b2 tails is also evidenced by ﬂuores-
cence resonance energy transfer (FRET) study [27]. Hence,
we generated C-terminal truncated variants aMLP1110* and
aMXN1133* such that the length of their aL and aX cytoplas-
mic elements are comparable to that of the aM tail (Fig. 2B).
Signiﬁcant Hck accumulation at the periphery of the phagocy-
tosed-OZ could be detected in aMLP1110*b2 and
aMXN1133*b2 transfectants (Fig. 3E).
A membrane proximal salt-bridge of the integrin tails is
formed by a highly conserved Arg and an Asp in the a and
b tails, respectively [28]. Salt-bridge disruption activates inte-
grin by promoting the separation of its tails [27]. Therefore,
b2D709R variant having its Asp
709 substituted with Arg was
generated (Fig. 2C). Marked accumulation of Hck around
phagocytosed-OZ was detected in aMLb2D709R and
aMXb2D709R transfectants (Fig. 3E).
The binding properties of aMb2, aMLb2, or aMXb2 transfec-
tants may be similar at high coating-concentration (7.5 lg/
mL) of iC3b as shown in Fig. 3B. However, at lower concen-
trations of iC3b, diﬀerence in binding capacities amongst these
transfectants may account for the diﬀerence in subsequent Hck
recruitment during phagocytosis of OZ as observed for aMb2,
aMLb2, and aMXb2. To resolve this concern, we examined the
binding of aMb2, aMLb2, aMXb2, aMb2D709R, aMLb2D709R,
aMXb2D709R, aMLP1110*b2, and aMXN1133*b2 transfectants
on varying concentrations of iC3b (Fig. 4). All variants had
similar cell surface expression proﬁles as compared to that of
aMb2 (Fig. 4A). Further, comparable iC3b-binding proﬁles
were observed for aMb2, aMLb2, aMXb2, aMLP1110*b2, and
aMXN1133*b2 transfectants even at low concentration (0.3 lg/
mL) of iC3b without or with activating mAb KIM185. The
aMb2D709R, aMLb2D709R, and aMXb2D709R transfectants
showed higher level of iC3b-binding as compared to aMb2 in
the absence of KIM185, which corroborates well with en-
hanced integrin activity as a result of salt-bridge disruption
[27]. Taken together, these data suggest that the lack of Hck
accumulation at the periphery of the phagocytosed-OZ in
aMLb2 or aMXb2 transfectants as compared to transfectants
expressing aMb2 and other variants could not be due to lower
ligand-binding aﬃnity but was attributed to intrinsic diﬀer-
ences in the cytoplasmic tails as demonstrated in this study.3.4. b2 tail sequence Asp
728-Ser734 is required for Hck
recruitment
Hck was reported to interact with b2 tail in pull-down anal-
yses using platelet lysate and puriﬁed recombinant b2 tail pro-
tein [24]. However, we were unable to co-immunoprecipitate
Hck with aMb2 from lysates of THP-1 or transfectants
although aMb2 was eﬀectively precipitated (data not shown).
What accounts for this discrepancy is unclear. It is possible
that co-capping of aMb2 and Hck may involve an adaptor pro-
tein that is susceptible to disruption under conditions of immu-
noprecipitation. Notwithstanding, we generated truncated b2
tail variants (b2M740*, b2S734*, b2N727*, and b2K702*) with
sequential deletion from their C-termini (Fig. 2C) and exam-
ined their eﬀects on the co-capping of aMb2 and Hck in trans-
fectants (Fig. 5). aMb2, aMb2M740*, and aMb2S734* co-capped
with Hck. This was markedly diminished in aMb2N727* and
aMb2K702*. These data suggest that the b2 tail sequence
Asp728-Ser734 is required for Hck recruitment to aMb2.4. Discussion
Hck is involved in the activation of neutrophils and mono-
cytes mediated by Fc receptor [29,30]. Hck is also implicated
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double knockout mice of Hck and another SFK c-Fgr, which
it shares overlapping functions [31], exhibit impaired integrin-
mediated signaling [32]. Neutrophils from hck/fgr/ mice
had impaired b2 integrin-induced respiratory burst [33]. Fur-
ther, it was reported that Hck accumulates around phagosome
that contains OZ in neutrophils [10]. Interestingly, Hck was
shown to be activated in neutrophils and diﬀerentiated human
promyelocytic NB4 cells that were allowed to phagocytosed
OZ [34]. There are also evidences suggesting a role of activated
Hck in regulating aMb2 mediated adhesion in neutrophils
[35,36]. These data lend support to the importance of Hck in
integrin-mediated functions of polymorphonuclear leukocytes.
Integrin triggers intracellular signaling cascades by the inter-
action of cytosolic proteins with its cytoplasmic tails. This
study demonstrates a primary role of the a tails in determining
Hck recruitment to the leukocyte integrin aMb2 but not aLb2
or aXb2. What is the underlying mechanism? Speciﬁc binding
of paxillin to the a4 tail aﬀects focal adhesion kinase (FAK)
phosphorylation and recruitment by integrin a4b1 [37–39]. It
is therefore possible that intrinsic variations in the length, com-
position, or modiﬁcation such as phosphorylation status of the
aL or aX tail as compared to aM may specify its association
with diﬀerent cytosolic proteins. These factors, yet to be iden-
tiﬁed, prevent Hck recruitment by the b2 tail. Indeed, we ob-
served that a reduction in length of the aL or aX tail in
aMLb2 or aMXb2 made comparable to that of aM restored
co-localization with Hck. However, we do not exclude the pos-
sibility of a tail directly aﬀecting the function of the b2 tail. The
highly-charged cytoplasmic C-terminal half of aIIb is reported
to regulate aIIbb3 activity perhaps via direct inter-molecular
interaction between its two tails [25]. Our data on the restora-
tion of Hck co-localization with salt-bridge disrupted variants
aMLb2D709R and aMXb2D709R suggest that the close proxim-
ity and possibly interaction of the aL or aX with b2 tail may
prevent Hck recruitment to the b2 tail. Structural determina-
tion of these cytoplasmic tails, which is currently lacking for
the b2 integrins, will be required to deﬁne these molecular
mechanisms. Although we could not show direct interaction
between Hck and the b2 tail as reported [24], our data suggest
that the region Asp728-Ser734 of the b2 tail is required for eﬀec-
tive Hck and aMb2 co-capping. Interestingly, this region con-
tains an NPLF motif that is highly conserved amongst
several integrin b tails. Talin, a widely expressed cytoplasmic
protein that serves to maintain the connectivity between inte-
grins and actin cytoskeleton, binds to a corresponding motif
in the b3 tail [40]. Talin head domain also initiates integrin acti-
vation by promoting cytoplasmic tail separation and salt-
bridge disruption [27]. Therefore, the possibility of functional
co-operativity between aMb2, Hck, and talin warrants further
investigations.Acknowledgements: We thank the support of the Nanyang Technolog-
ical University Grant M52080022 and the Singapore Agency for Sci-
ence, Technology, and Research (A*STAR) Biomedical Research
Council Grant 04/1/22/19/358.References
[1] Hynes, R.O. (2002) Integrins: bidirectional, allosteric signaling
machines. Cell 110, 673–687.[2] Liu, S., Calderwood, D.A. and Ginsberg, M.H. (2000) Integrin
cytoplasmic domain-binding proteins. J. Cell Sci. 113, 3563–3571.
[3] Berton, G., Laudanna, C., Sorio, C. and Rossi, F. (1992)
Generation of signals activating neutrophil functions by leukocyte
integrins: LFA-1 and gp150/95, but not CR3, are able to stimulate
the respiratory burst of human neutrophils. J. Cell Biol. 116,
1007–1017.
[4] Whitlock, B.B., Gardai, S., Fadok, V., Bratton, D. and Henson,
P.M. (2000) Diﬀerential roles for aMb2 integrin clustering or
activation in the control of apoptosis via regulation of akt and
ERK survival mechanisms. J. Cell Biol. 151, 1305–1320.
[5] Weber, K.S., Klickstein, L.B. and Weber, C. (1999) Speciﬁc
activation of leukocyte b2 integrins lymphocyte function-associ-
ated antigen-1 and Mac-1 by chemokines mediated by distinct
pathways via the a subunit cytoplasmic domains. Mol. Biol. Cell
10, 861–873.
[6] Shattil, S.J. (2005) Integrins and Src: dynamic duo of adhesion
signaling. Trends Cell Biol. 15, 399–403.
[7] Ehlers, M.R. (2000) CR3: a general purpose adhesion-recognition
receptor essential for innate immunity. Microbes Infect. 2, 289–
294.
[8] Caron, E. and Hall, A. (1998) Identiﬁcation of two distinct
mechanisms of phagocytosis controlled by diﬀerent Rho GTP-
ases. Science 282, 1717–1721.
[9] Thomas, S.M. and Brugge, J.S. (1997) Cellular functions regu-
lated by Src family kinases. Annu. Rev. Cell Dev. Biol. 13, 513–
609.
[10] Mohn, H., Le Cabec, V., Fischer, S. and Maridonneau-Parini, I.
(1995) The src-family protein-tyrosine kinase p59hck is located on
the secretory granules in human neutrophils and translocates
towards the phagosome during cell activation. Biochem. J. 309,
657–665.
[11] Astarie-Dequeker, C., Carreno, S., Cougoule, C. and Maridon-
neau-Parini, I. (2002) The protein tyrosine kinase Hck is located
on lysosomal vesicles that are physically and functionally distinct
from CD63-positive lysosomes in human macrophages. J. Cell
Sci. 115, 81–89.
[12] Hildreth, J.E., Gotch, F.M., Hildreth, P.D. and McMichael, A.J.
(1983) A human lymphocyte-associated antigen involved in cell-
mediated lympholysis. Eur. J. Immunol. 13, 202–208.
[13] Uciechowski, P. and von Schmidt, R.E. (1989) Leucocyte Typing
IV White Cell Diﬀerentiation Antigens, Oxford University Press,
Oxford, UK, pp. 543–551.
[14] Mathew, E.C., Shaw, J.M., Bonilla, F.A., Law, S.K. and Wright,
D.A. (2000) A novel point mutation in CD18 causing the
expression of dysfunctional CD11/CD18 leucocyte integrins in a
patient with leucocyte adhesion deﬁciency (LAD). Clin. Exp.
Immunol. 121, 133–138.
[15] Andrew, D., Shock, A., Ball, E., Ortlepp, S., Bell, J. and
Robinson, M. (1993) KIM185, a monoclonal antibody to CD18
which induces a change in the conformation of CD18 and
promotes both LFA-1- and CR3-dependent adhesion. Eur. J.
Immunol. 23, 2217–2222.
[16] Wright, S.D., Rao, P.E., Van Voorhis, W.C., Craigmyle, L.S.,
Iida, K., Talle, M.A., Westberg, E.F., Goldstein, G. and
Silverstein, S.C. (1983) Identiﬁcation of the C3bi receptor of
human monocytes and macrophages by using monoclonal anti-
bodies. Proc. Natl. Acad. Sci. USA 80, 5699–5703.
[17] Tan, S.M., Hyland, R.H., Al-Shamkhani, A., Douglass, W.A.,
Shaw, J.M. and Law, S.K. (2000) Eﬀect of integrin b2 subunit
truncations on LFA-1 (CD11a/CD18) and Mac-1 (CD11b/CD18)
assembly, surface expression, and function. J. Immunol. 165,
2574–2581.
[18] Barclay, A.N., Brown, M.H., Law, S.K., McKnight, A.J.,
Tomlinson, M.G. and van der Merwe, P.A. (1997) The Leucocyte
Antigen Facts Book, Academic Press, London, UK.
[19] Xiao, J.H., Davidson, I., Matthes, H., Garnier, J.M. and
Chambon, P. (1991) Cloning, expression, and transcriptional
properties of the human enhancer factor TEF-1. Cell 65, 551–568.
[20] Manser, E., Huang, H.Y., Loo, T.H., Chen, X.Q., Dong, J.M.,
Leung, T. and Lim, L. (1997) Expression of constitutively active
a-PAK reveals eﬀects of the kinase on actin and focal complexes.
Mol. Cell Biol. 17, 1129–1143.
[21] Cai, T.Q. and Wright, S.D. (1995) Energetics of leukocyte integrin
activation. J. Biol. Chem. 270, 14358–14365.
4442 R.-H. Tang et al. / FEBS Letters 580 (2006) 4435–4442[22] Auwerx, J. (1991) The human leukemia cell line, THP-1: a
multifacetted model for the study of monocyte-macrophage
diﬀerentiation. Experientia 47, 22–31.
[23] Kim, P.W., Sun, Z.Y., Blacklow, S.C., Wagner, G. and Eck, M.J.
(2003) A zinc clasp structure tethers Lck to T cell coreceptors
CD4 and CD8. Science 301, 1725–1728.
[24] Arias-Salgado, E.G., Lizano, S., Sarkar, S., Brugge, J.S., Gins-
berg, M.H. and Shattil, S.J. (2003) Src kinase activation by direct
interaction with the integrin b cytoplasmic domain. Proc. Natl.
Acad. Sci. USA 100, 13298–13302.
[25] Vinogradova, O., Haas, T., Plow, E.F. and Qin, J. (2000) A
structural basis for integrin activation by the cytoplasmic tail of
the aIIb-subunit. Proc. Natl. Acad. Sci. USA 97, 1450–1455.
[26] Vinogradova, O., Velyvis, A., Velyviene, A., Hu, B., Haas, T.,
Plow, E. and Qin, J. (2002) A structural mechanism of integrin
aIIbb3 ‘‘inside-out’’ activation as regulated by its cytoplasmic face.
Cell 110, 587–597.
[27] Kim, M., Carman, C.V. and Springer, T.A. (2003) Bidirectional
transmembrane signaling by cytoplasmic domain separation in
integrins. Science 301, 1720–1725.
[28] Hughes, P.E., Diaz-Gonzalez, F., Leong, L., Wu, C., McDonald,
J.A., Shattil, S.J. and Ginsberg, M.H. (1996) Breaking the integrin
hinge. A deﬁned structural constraint regulates integrin signaling.
J. Biol. Chem. 271, 6571–6574.
[29] Zhou, M.J., Lublin, D.M., Link, D.C. and Brown, E.J. (1995)
Distinct tyrosine kinase activation and Triton X-100 insolubility
upon Fc gamma RII or Fc gamma RIIIB ligation in human
polymorphonuclear leukocytes. Implications for immune complex
activation of the respiratory burst. J. Biol. Chem. 270, 13553–
13560.
[30] Durden, D.L., Kim, H.M., Calore, B. and Liu, Y. (1995) The Fc
gamma RI receptor signals through the activation of hck and
MAP kinase. J. Immunol. 154, 4039–4047.
[31] Lowell, C.A., Soriano, P. and Varmus, H.E. (1994) Functional
overlap in the src gene family: inactivation of hck and fgr impairs
natural immunity. Genes Dev. 8, 387–398.
[32] Suen, P.W., Ilic, D., Caveggion, E., Berton, G., Damsky, C.H.
and Lowell, C.A. (1999) Impaired integrin-mediated signaltransduction, altered cytoskeletal structure and reduced motil-
ity in Hck/Fgr deﬁcient macrophages. J. Cell Sci. 112, 4067–
4078.
[33] Lowell, C.A., Fumagalli, L. and Berton, G. (1996) Deﬁciency of
Src family kinases p59/61hck and p58c-fgr results in defective
adhesion-dependent neutrophil functions. J. Cell Biol. 133, 895–
910.
[34] Welch, H. and Maridonneau-Parini, I. (1997) Hck is activated by
opsonized zymosan and A23187 in distinct subcellular fractions of
human granulocytes. J. Biol. Chem. 272, 102–109.
[35] Piccardoni, P., Sideri, R., Manarini, S., Piccoli, A., Martelli, N.,
de Gaetano, G., Cerletti, C. and Evangelista, V. (2001) Platelet/
polymorphonuclear leukocyte adhesion: a new role for SRC
kinases in Mac-1 adhesive function triggered by P-selectin. Blood
98, 108–116.
[36] Totani, L., Piccoli, A., Manarini, S., Federico, L., Pecce, R.,
Martelli, N., Cerletti, C., Piccardoni, P., Lowell, C.A., Smyth,
S.S., Berton, G. and Evangelista, V. (2006) Src-family kinases
mediate an outside-in signal necessary for b2 integrins to
achieve full activation and sustain ﬁrm adhesion of polymor-
phonuclear leucocytes tethered on E-selectin. Biochem. J. 396,
89–98.
[37] Schaller, M.D., Otey, C.A., Hildebrand, J.D. and Parsons, J.T.
(1995) Focal adhesion kinase and paxillin bind to peptides
mimicking beta integrin cytoplasmic domains. J. Cell Biol. 130,
1181–1187.
[38] Liu, S., Thomas, S.M., Woodside, D.G., Rose, D.M., Kiosses,
W.B., Pfaﬀ, M. and Ginsberg, M.H. (1999) Binding of paxillin to
a4 integrins modiﬁes integrin-dependent biological responses.
Nature 402, 676–681.
[39] Han, J., Liu, S., Rose, D.M., Schlaepfer, D.D., McDonald, H.
and Ginsberg, M.H. (2001) Phosphorylation of the integrin a4
cytoplasmic domain regulates paxillin binding. J. Biol. Chem. 276,
40903–40909.
[40] Garcia-Alvarez, B., de Pereda, J.M., Calderwood, D.A., Ulmer,
T.S., Critchley, D., Campbell, I.D., Ginsberg, M.H. and Lidd-
ington, R.C. (2003) Structural determinants of integrin recogni-
tion by talin. Mol. Cell 11, 49–58.
